Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2478-2021Class II

Medtronic HVAD Pump Implant Kits

HeartWare, Inc. / initiated 2021-08-06 / Open, Classified / root cause: design

Heartware, Inc. began a recall of Medtronic HVAD Pump Implant Kits on . FDA classified it as Class II and gives the reason as "There is more force required to slide the driveline cover (boot cover) away from the connector after completion of a Driveline Strain Relief Repair than over an unrepaired strain relief. This may lead to difficulty in...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as design.

Recall record

Recall number
Z-2478-2021
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
HeartWare, Inc.
Product
Medtronic HVAD Pump Implant Kits
Product code
DSQ Ventricular (Assist) Bypass
Reason for recall
There is more force required to slide the driveline cover (boot cover) away from the connector after completion of a Driveline Strain Relief Repair than over an unrepaired strain relief. This may lead to difficulty in pulling back the driveline cover when attempting to access the Driveline connector during a controller exchange. Additionally, sliding the driveline cover over a strain relief repair may compromise the repair.
Root cause tag
design
FDA root cause
Device Design
Action
Beginning 10-Aug-2021 (US), and no later than 17-Aug-2021 (OUS), Medtronic initiated a Global notification to inform HVAD clinicians (following physicians and VAD Coordinators at HVAD accounts) who are currently treating patients implanted with the HVAD system about the potential for difficulty in pulling back the HVAD Pump Driveline cover for drivelines that have received a strain relief repair. In the United States, beginning 10-Aug-2021, an Urgent Medical Device Notice, was delivered to following physicians and VAD Coordinators, who are currently caring for an HVAD patient, via UPS 2-day delivery as well as through verbal and in person follow ups from the Medtronic field staff. Also, in the United States, on 17-Aug-2021, Medtronic sent a notification to active HVAD Patients in the U.S. according to their registered contact information via UPS 2-day delivery to make them aware of the potential for this issue and to reinforce precautions in the IFU and Patient Manual cautioning against selfrepairing the HVAD equipment. Outside of the United States, beginning 10-Aug-2021 and no later than 17-Aug-2021, a formal FCA notification will be delivered to VAD Coordinators and following physicians who according to Medtronic records are treating patients implanted with an HVAD system. This letter will be delivered using locally approved methods. Confirmation of the communication will be received via locally approved methods.
Quantity in commerce
11851 (potentially active, US); 1995 (active, US)
Distribution
Distribution throughout the US. Also distribution in ARGENTINA Armenia, Australia, Austria, BELGIUM, BRAZIL, CANADA, CHILE, Colombia, CROATIA, CZECH REPUBLIC, DENMARK, EGYPT, ESTONIA, FINLAND, FRANCE, Germany, GREECE HONG KONG, HUNGARY, INDIA, ISRAEL, Italy, JAPAN, Kazakhstan, Korea, KUWAIT, Latvia, LEBANON, LITHUANIA, LUXEMBOURG, Macedonia, MALAYSIA, NETHERLANDS, NEW ZEALAND, NORWAY, Poland, ROMANIA, SAUDI ARABIA, Serbia, Singapore, SLOVAKIA, SOUTH AFRICA, SPAIN, SWEDEN, SWITZERLAND, Taiwan, TURKEY, Ukraine, United Arab Emirates, United Kingdom, VIETNAM
Product codes and lots
Product Numbers: 1100, 1101, 1102, 1103, 1104, 1104JP, 1205, and MCS1705PU - all serial numbers

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2478-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2478-2021Class IIOngoingVoluntary: Firm initiated